THE MANAGEMENT OF THYROTOXICOSIS BY THERAPEUTIC PLASMA EXCHANGE IN PATIENTS COMPLICATED WITH ANTITHYROID DRUGS

Basit Öğe Kaydı
dc.authorwosidTurgut, Burhan/A-2517-2016
dc.contributor.authorSezer, A.
dc.contributor.authorGuldiken, S.
dc.contributor.authorTurgut, B.
dc.contributor.authorIrfanoglu, M. E.
dc.date.accessioned2024-06-12T11:16:26Z
dc.date.available2024-06-12T11:16:26Z
dc.date.issued2011
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective. Antithyroid drugs, surgical excision, and radiation therapy with I-131 are the common treatment modalities thyrotoxicosis. The medical treatment of thyrotoxicosis has approximately 0.35% serious complications which consist of agranulocytosis, liver necrosis and failure. Therapeutic plasma exchange is an effective preoperative preparation method in thyrotoxicosis patients who are candidates for surgery and unable to manage an euthyroid state with medical treatment. Patients and Methods. This study was constructed between 2002-2009 in 9 patients who were resistant or had complications with medical treatment of thyrotoxicosis. The therapeutic plasma exchange procedures were performed with discontinuous flow cell separator devices. Results. Seven patients were females and 2 patients were males. The mean age was 51.22 years (32-78 years). The mean duration of the disease was 35.4 months (3-120 months). The patients underwent 3.3 (2-6 sessions) session of therapeutic plasma exchange before surgery. The mean volume of plasma exchange was 10549 mL (7150-18372 mL). The plasma is exchanged with %10 albumin and/or fresh frozen plasma. The complication rate was 22% during therapeutic plasma exchange. Four patients underwent near total thyroidectomy and five patients underwent total thyroidectomy. The mortality rate was zero. Neck hematoma causing acute respiratory compromise and requiring urgent evacuation developed in one patient. Conclusions. Total plasma exchange is an effective and safe procedure in preoperative preparation of the patients with thyrotoxicosis who were resistant or complicated with antithyroid drug in which a high level of concern and steady supervision is mandatory to prevent life threatening preoperative and postoperative complications.en_US
dc.identifier.doi10.4183/aeb.2011.239
dc.identifier.endpage247en_US
dc.identifier.issn1841-0987
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-84875854065en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage239en_US
dc.identifier.urihttps://doi.org/10.4183/aeb.2011.239
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24305
dc.identifier.volume7en_US
dc.identifier.wosWOS:000292125100009en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherEditura Acad Romaneen_US
dc.relation.ispartofActa Endocrinologica-Bucharesten_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectThyrotoxicosisen_US
dc.subjectTherapeutic Plasma Exchangeen_US
dc.subjectAntithyroid Drugsen_US
dc.subjectSurgeryen_US
dc.subjectSevere Graves Ophthalmopathyen_US
dc.subjectPlasmapheresisen_US
dc.subjectHyperthyroidismen_US
dc.subjectThyroidectomyen_US
dc.titleTHE MANAGEMENT OF THYROTOXICOSIS BY THERAPEUTIC PLASMA EXCHANGE IN PATIENTS COMPLICATED WITH ANTITHYROID DRUGSen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu